I suppose the pending announcement on the FDA approval for trialling Veyonda against Covid-19 will be used as a catalyst to bolster the SP in the coming weeks.
From a TA point of view I see this possibly having a nudge between 29c to 35c and may get there with that news within the specified 4 weeks. My mobile chart is a little crude but you can see an inverse H&S pattern there.
- Forums
- ASX - By Stock
- NOX
- Ann: Noxopharm March 2020 Quarterly Report & Appendix 4C
NOX
noxopharm limited
Add to My Watchlist
7.94%
!
6.8¢

Ann: Noxopharm March 2020 Quarterly Report & Appendix 4C, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.8¢ |
Change
0.005(7.94%) |
Mkt cap ! $19.87M |
Open | High | Low | Value | Volume |
6.5¢ | 6.9¢ | 6.5¢ | $48.42K | 724.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.8¢ | 2284 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30000 | 0.067 |
1 | 59378 | 0.066 |
1 | 16393 | 0.061 |
1 | 20000 | 0.059 |
1 | 15000 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 2284 | 1 |
0.069 | 90409 | 1 |
0.070 | 261666 | 1 |
0.072 | 43942 | 1 |
0.079 | 50000 | 1 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |